Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis.

MLA

Oh, Joo Hyun, et al. “Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis.” Journal of Personalized Medicine, vol. 12, no. 12, Nov. 2022. EBSCOhost, https://doi.org/10.3390/jpm12121957.

APA

Oh, J. H., Park, D. A., Ko, M. J., Yoo, J.-J., Yim, S. Y., Ahn, J.-H., Jun, D. W., & Ahn, S. B. (2022). Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine, 12(12). https://doi.org/10.3390/jpm12121957

Chicago

Oh, Joo Hyun, Dong Ah Park, Min Jung Ko, Jeong-Ju Yoo, Sun Young Yim, Ji-Hyun Ahn, Dae Won Jun, and Sang Bong Ahn. 2022. “Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis.” Journal of Personalized Medicine 12 (12). doi:10.3390/jpm12121957.